Skip to content
primarysourced Photonics sector Tower
TSEM
~6 min read · 1,471 words ·updated 2026-04-29 · confidence 17%

Confidence legend: ✓ verified-primary (Form 20-F Item 6, Tower investor-relations leadership page, Tower press release) · ◐ partial / aggregator (Wikipedia, LinkedIn, trade press) · ⚠ inferred / estimate / awaiting primary citation.

This page is the canonical reference for any thesis claim that turns on Tower Semiconductor’s executive bench. The official Tower investor-relations leadership page at towersemi.com/about/leadership/ is the authoritative current-state list; bios are sourced from individual Tower leadership profiles, the FY2024 Form 20-F Item 6 (filed 2025-04-30, accession 0001178913-25-001537), and recent Tower press releases.

The headline operating fact is operational continuity. Russell Ellwanger has been CEO since 2005 — a tenure now in its third decade and unusually long for a US-listed semiconductor company. Through the 2008 Jazz acquisition, the 2014 TPSCo joint venture formation, the 2020 TPSCo ownership flip with Nuvoton, the 2022 Intel acquisition announcement, the 2023 Intel-deal collapse, and the 2026 LWLG development agreement, Ellwanger has been the constant. Oren Shirazi has been CFO for a similarly long stretch. For an analyst, this means strategic narrative continuity is exceptionally high at Tower — there is no recent leadership-transition execution risk to discount.

Chief Executive Officer

Russell Ellwanger — Chief Executive Officer (since 2005); Director

  • Tenure: ~21 years as CEO; one of the longest-serving CEOs in the US-listed semiconductor universe.
  • Pre-Tower career: Senior leadership roles at Applied Materials (general manager of multiple business units) and earlier roles in semiconductor-equipment industry. Career-long focus on capital-equipment and foundry operations. ◐ Tower IR — Russell Ellwanger bio ; ⚠ confirm exact pre-Tower role titles in 20-F Item 6.A bio narrative.
  • Strategic orientation: Specialty-foundry positioning — Ellwanger has consistently framed Tower as a “complementary, not competitive” foundry to TSMC / GlobalFoundries / UMC, focused on differentiated specialty-analog (RF, power management, image sensors, MEMS, SiGe BiCMOS, silicon photonics) rather than leading-edge digital logic.
  • Intel deal cycle: Ellwanger remained CEO through the entire 2022-02 announcement → 2023-08 termination arc and continues to lead post-collapse. The continuity is itself a signal that the board viewed the deal collapse as exogenous (China antitrust) rather than execution-related. ⚠ analyst inference; not a primary-source claim.

Key context: Ellwanger’s personal continuity through the Intel deal is one of the more underappreciated facts about Tower as an investment. Most acquirees see CEO turnover post-deal-collapse — the operating leader either departs over strategic friction with the would-be acquirer or is replaced as the board recasts. Tower kept its CEO and its strategy; the company emerged from the failed deal with the same playbook plus a $353M cash injection from the reverse-termination fee. The investor-facing implication is that the post-2023 Tower has the same strategic muscle memory as the pre-2022 Tower — there is no “new strategy under new leadership” overhang to evaluate.

Chief Financial Officer

Oren Shirazi — Chief Financial Officer

  • Tenure: Long-tenured CFO; in role since the late 2000s. ⚠ exact start date to be confirmed in 20-F Item 6.A bio.
  • Pre-Tower career: Internal Tower career path — held finance-controller and SVP Finance roles at Tower before promotion to CFO. ◐ Tower IR — Oren Shirazi bio ; ⚠ confirm pre-Tower employers in 20-F Item 6.A.
  • Education: ⚠ confirm in 20-F Item 6.A.

Key context: The Ellwanger-Shirazi CEO-CFO pairing has been intact for substantially the entire 2008-Jazz-onward era. This is unusual stability for the C-suite of a $1B+ revenue specialty foundry. From a corporate-governance standpoint, it implies a high level of board-management trust and minimal principal-agent friction; from an analyst standpoint, it means historical financial disclosures are directly comparable across cycles because the same accounting hands have prepared them.

Other Executive Officers (named in 20-F Item 6.A)

The following executive officers are typically disclosed in Tower’s 20-F Item 6.A. ⚠ Individual names and exact titles are subject to refresh from the filed 20-F (accession 0001178913-25-001537); the categories below are stable but the title-and-name pairings should be verified.

  • Chief Operating Officer / Senior VP Operations — operational ownership of the Migdal Haemek Fab 1 + Fab 2, Newport Beach Fab 3, and the TPSCo / Tower-ST capacity-allocation arrangements. ⚠ confirm name in 20-F.
  • Senior VP Worldwide Sales / Chief Business Officer — customer-facing GTM, design wins, and key-account management. Functional ownership of the LWLG / RF-customer / power-management / image-sensor relationships. ⚠ confirm name in 20-F.
  • Senior VP Technology / CTO — technology development across PH18 silicon-photonics, the SiGe BiCMOS RF franchises, the BCD power-management process families, and the Tower-ST 300mm transition. ⚠ confirm name in 20-F.
  • Senior VP / GM Newport Beach — site P&L for the US 200mm operations including the legacy Jazz line and the 2023-acquired Maxim line. ⚠ confirm name in 20-F.
  • Senior VP / GM Japan (TPSCo) — site P&L for the Uozu and Arai facilities and the Nuvoton-JV operating relationship. ⚠ confirm name in 20-F.

The 20-F Item 6.A typically discloses 5–8 officers in addition to CEO and CFO. The next refresh should extract individual names and tenure data from the filed document.

✓ Tower investor-relations leadership team page is the authoritative current-state source.

Board of Directors

Amir Elstein — Chairman of the Board (since 2009; reconfirmed annually)

  • Tenure as Chair: ~16+ years.
  • Pre-Tower career: Long career at Intel in Israel and globally, including senior operations roles; later, a multi-board director and chairman across Israeli technology companies. Elstein is a recognized senior figure in the Israeli high-tech ecosystem.
  • Role at Tower: Independent (non-management) board chair. Provides board-level continuity through the Intel deal cycle and post-collapse standalone era. ◐ Tower IR — board page ; ⚠ confirm independence classification and committee assignments in 20-F Item 6.C.

Other Directors (to be enumerated from 20-F Item 6.C)

The Tower board typically comprises ~7–9 directors with a mix of industry executives, former Tower senior management (Ellwanger sits on the board ex officio as CEO), and independent directors required under Israeli Companies Law (including external directors / dahatzim). The board has subcommittees for Audit, Compensation, and Nominating / Corporate Governance.

⚠ Individual director names, tenures, and committee assignments to be extracted from the FY2024 20-F Item 6.C filed 2025-04-30 (accession 0001178913-25-001537) in the next refresh.

Israeli Companies Law specifics: As an Israeli-incorporated FPI, Tower must comply with the Israeli Companies Law, 5759-1999, including:

  • External directors (dahatzim) — at least two independent directors with specified qualifications, serving fixed three-year terms.
  • Audit committee composition rules — minimum 50% independent / external-director composition.
  • Related-party transaction approval rules — three-stage (audit committee → board → shareholders) approval for officer-and-director-related-party transactions.

These mechanics produce a more shareholder-protective governance regime than would be required under Delaware law alone. Cross-reference: Governance for the full Israeli-Companies-Law-mechanics breakdown. ⚠ governance file pending population.

Form 4 Cadence (Post-HFIAA)

Effective 2026-03-18 under the Holding Foreign Insiders Accountable Act, TSEM officers / directors / 10%+ holders began filing Section 16(a) reports. The site’s daily-refresh pipeline will capture these via the standard Form 3 / Form 4 / Form 5 ingest path:

  • Form 3 (initial holdings): due within 90 days of 2026-03-18 = by 2026-06-16.
  • Form 4 (transactions): due within 2 business days of any beneficial-ownership change.
  • Form 5 (annual): due 45 days after fiscal year-end (next deadline 2027-02-15 covering FY2026 transactions).

⚠ As of the 2026-04-29 KB cutoff, no Tower Form 4 transactions have been observed. The first Tower Form 3 filings are due 2026-06-16; expect a cluster of filings in late May / early June. The first Form 4 transaction will be a noteworthy data point — it will signal whether Ellwanger / Shirazi / Elstein / other insiders are buying, selling, or holding off on trading their accumulated equity awards.

NEO Compensation Summary

⚠ The FY2024 Form 20-F Item 6.B contains the named-executive-officer compensation summary for FY2024. The next refresh should extract:

  • Russell Ellwanger (CEO; FY2024 total compensation, including base salary, bonus, equity grant, pension / severance).
  • Oren Shirazi (CFO; FY2024 total compensation).
  • Top 3 additional NEOs as disclosed.

Israeli Companies Law requires shareholder approval of CEO compensation (a “compensation policy” vote) at least once every three years and approval of any individual CEO pay package that materially deviates from the approved policy. Tower’s most recent compensation-policy approval cycle should be visible in the 20-F Item 6.B narrative.

Cross-section pointers

  • Governance — Director roster, Israeli Companies Law specifics, board-committee mechanics, external-director (dahatz) rules.
  • Timeline — Every appointment / departure row above resolves to a dated timeline entry.
  • Intel deal collapse — Ellwanger / Shirazi role through the 2022–2023 deal cycle.
  • M&A history — Acquisitions / dispositions executed under the current management team.
  • Financials overview — Compensation expense (stock-based comp, severance, change-of-control payouts) ties back to the Item 6.B disclosures.
  • Market data overview — Form 4 (post-2026-03-18) insider-transaction tracking once first filings appear.